Navigation Links
Immunicon Will Exhibit CellCapture CTC Mouse/Rat Kit and EasyCount,System for Automated Cell Counting at AACR

HUNTINGDON VALLEY, Pa.--(BUSINESS WIRE)--Apr 12, 2007 - Immunicon Corporation (NASDAQ-GM:IMMC) will exhibit at the American Association for Cancer Research (AACR) at the Los Angeles Convention Center, April 15 to 18. The Company will feature Immunicon Pharma Services(SM), the new CellCapture(TM) CTC Mouse/Rat Kit and the new EasyCount(TM) System at booth 1604.

Immunicon Pharma Services offers assay development and clinical trial testing services to some of the largest pharmaceutical and biotechnology companies in connection with cancer drug development programs. These companies diligently search for tools to move drug targets from discovery to product launch as cost-effectively and quickly as possible. Rare cells, such as Circulating tumor cells (CTCs) and circulating endothelial cells (CECs), can be used as biomarkers, and protein and gene expression associated with these rare cells may be useful to understand mechanism of action, pharmacodynamics and efficacy of cancer drugs. As an expert in rare cell analysis, Immunicon offers drug developers a unique partnership opportunity to accelerate their programs using CTCs and CECs or molecular biomarkers in clinical trials. Immunicon offers assay development services for its CellTracks(R) System rare cell technology, including biomarker assays for protein markers or fluorescence in situ hybridization (FISH) targets and new assay kit development for analysis of other rare cells. Immunicon's clinical trial testing services include testing CTCs or CECs as biomarkers in clinical trials and rare cell enrichment for downstream molecular analysis.

The CellCapture CTC Mouse/Rat Kit enables pre-clinical studies using animal models. The CellCapture Kit uses a manual test procedure to capture CTCs in a few drops of mouse blood and the cells are counted and characterized using the CellTracks(R) Analyzer II. This kit will enable scientists to conduct efficacy studies in v
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
2. ANA380 Exhibits Activity In Vitro Against Multiple Clinically Relevant Hepatitis B Virus Mutants

Post Your Comments:
(Date:11/6/2009)....C., Nov. 6 Chimerix, Inc., a biop...ntiviral therapeutics to address life-threatening ...the company,s lead antiviral compound, CMX001, to ... Health Security Initiative (GHSI). CMX001 is a b...the treatment of smallpox, as well as other seriou...
(Date:11/6/2009)...re-FirstCall/ -- Caraco Pharmaceutical Laboratorie...tromethamine ophthalmic solution, 0.5% following a...ration (FDA) for Sun Pharma,s Abbreviated New Drug...lmic solution on the first day following patent ex...cally equivalent to Acular® Ophthalmic Soluti...
(Date:11/5/2009)...swire/ -- Althea Technologies, Inc., a leading pro...r biopharmaceutical products announced the additio...pany,s platform of services, which will be oversee...tor of Formulation Development. This investment in... scientists, along with new laboratory facilities ...
Breaking Medicine Technology:Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2RiversEdge BioVentures LLC to Provide Advisory and Investment Services in Life Sciences 13993 1RiversEdge BioVentures LLC to Provide Advisory and Investment Services in Life Sciences 13993 2GENova to acquire three new drug target patents worth in excess of 241 billion in royalty fees 56862 1GENova to acquire three new drug target patents worth in excess of 241 billion in royalty fees 56862 2GENova to acquire three new drug target patents worth in excess of 241 billion in royalty fees 56862 3Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid 56858 1Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid 56858 2Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid 56858 3Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid 56858 4
...l Therapeutics (CTI),(Nasdaq and MTA: CTIC) announ...nd Drug Administration (FDA), CTI expects to begin...) and request priority review for pixantrone to tr...L) in the first quarter of 2009.,If granted priori... the end of,2009. , "This communication from t...
...t Angiolix has similar efficacy to Avastin alone a...th potentially less side-effects; study validates ...DALLAS, Jan. 26 ACCESS PHARMACEUTICALS, INC. (OTC...k on its proprietary humanized monoclonal antibody... with high affinity to the its target, lactadherin...
Other Medicine Technology:Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission 2Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission 3Access Pharmaceuticals Presents new Combination Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 2Access Pharmaceuticals Presents new Combination Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 3
(Date:11/8/2009)...jury of 8 people in the Western District of Pennsy...pain and suffering for a medical malpractice case....ia Nocera of Thomas E. Crenney and Associates, LLC... Monestersky and against the Uniontown Hospital. ... hysterectomy at age 18. , ...
(Date:11/8/2009)...Newswire-USNewswire/ -- Pharmaceutical Research an...sident Ken Johnson released the following statemen..., "We are disappointed, but not surprised by toda...rdworking Americans as well as nearly half of the ...oted against the bill. ,, "While well intention...
(Date:11/8/2009)...ssage of Health Care Reform Bill ,, Critical ...erage for all Americans ,, BALTIMORE, Nov. 7 /...nited States House of Representatives passed criti...ngthen Medicare for seniors and end discrimination...ericans out of affordable health coverage. ,, T...
(Date:11/7/2009)...swire-USNewswire/ -- The American Medical Associat...f Health at the Family Violence Prevention Fund, w...t its semi-annual policy-making meeting. The Cita...r the AMA House of Delegates bestows on a non-phys...i-bin/prnh/20081209/AMALOGO ) ,, "Ms. James h...
(Date:11/7/2009)...holics have a responsibility to vigorously oppose ...uo." ,, WASHINGTON, Nov. 7 /PRNewswire-USNe...rown released the following statement on the news ...ancy Pelosi,s Affordable Health Care for America A...he status quo for abortion is voted upon. ,, "...
Breaking Medicine News(10 mins):Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors Family Violence Prevention Expert 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2
... prescribed to lower cholesterol, may have protect...inic cohort study looked at three different aspect...tile dysfunction and prostate enlargement. Initial...al audio and video resources, including excerpts f...
...that outcomes of robotic assisted kidney cancer su...igh volume centers, prove more beneficial to patie...hored by Fox Chase robotic surgeon Rosalia Viterbo...ve the entire or a portion of the kidney. This is ...
...rts to cut back, , , SATURDAY, April 25 (H... the most important lifestyle changes people with ... the recommendation, a new study has found. , Res...e with heart failure is 2,000 milligrams, particip...
...astic Surgery increased too, with breast implants ..., bigger bank balances and stunning senior celebs ... April 25 A NEW trend in beauty has been seen by ...ving non-surgical treatments including Botox, derm...
...nsurance coverage affect their access to quality c...Cancer Center, insurance coverage may not only aff...e quality of care they receive. Research findings,...scovered a discrepancy in the type of surgical tre...
...tiple doctors who write prescriptions for drugs to...more on the importance of making sure that every d...sten to this report from Prescription Solutions at...xt, graphics and photos for free and unrestricted ...
Other Medicine News:Health News:Major statin study reveals several important findings for reducing prostate cancer and disease 2Health News:Major statin study reveals several important findings for reducing prostate cancer and disease 3Health News:Major statin study reveals several important findings for reducing prostate cancer and disease 4Health News:Robotic assisted kidney cancer surgery proves to be beneficial to patients 2Health News:Hidden Salt in Diet Haunts Many With Heart Failure 2Health News:Growth of Plastic Surgery & Botox Grannies in UK 2Health News:Growth of Plastic Surgery & Botox Grannies in UK 3Health News:Does a person's insurance coverage affect their access to quality cancer care? 2
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: